Therapy with proton-pump inhibitors for gastroesophageal reflux disease does not reduce the risk for severe exacerbations in COPD

Luzia Baumeler, Eleni Papakonstantinou, Branislava Milenkovic, Alicia Lacoma, Renaud Louis, Joachim G. Aerts, Tobias Welte, Konstantinos Kostikas, Francesco Blasi, Wim Boersma, Antoni Torres, Gernot G. U. Rohde, Lucas Boeck, Janko Rakic, Andreas Scherr, Michael Tamm, Daiana Stolz

Research output: Contribution to journalArticleAcademicpeer-review

4 Citations (Scopus)
Original languageEnglish
Pages (from-to)883-890
JournalRespirology
Volume21
Issue number5
DOIs
Publication statusPublished - Jul 2016

Keywords

  • anti-gastroesophageal reflux disease therapy
  • chronic obstructive pulmonary disease
  • chronic obstructive pulmonary disease exacerbations
  • gastroesophageal reflux disease
  • proton pump inhibitors

Cite this

Baumeler, L., Papakonstantinou, E., Milenkovic, B., Lacoma, A., Louis, R., Aerts, J. G., Welte, T., Kostikas, K., Blasi, F., Boersma, W., Torres, A., Rohde, G. G. U., Boeck, L., Rakic, J., Scherr, A., Tamm, M., & Stolz, D. (2016). Therapy with proton-pump inhibitors for gastroesophageal reflux disease does not reduce the risk for severe exacerbations in COPD. Respirology, 21(5), 883-890. https://doi.org/10.1111/resp.12758